在低氧视网膜病变中,mTOR下调促进通过CCL3-CCR5轴的抗炎反应
Tae Kwon Moon1,2, Im Kyeung Kang1,2, Kyoung Jin Lee2,3
1Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Molecular therapy. Methods & clinical development
|February 3, 2025
概括
通过向mTOR和CCL3-CCR5通路,AAV2-shmTOR基因疗法可以减少缺氧视网膜病变的炎症. 这种方法为这些视网膜疾病引起的视力障碍提供了一个有希望的新疗法.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 缺氧视网膜病变,如糖尿病视网膜病变,通过炎症和血管生成导致视力丧失.
- 已知AAV2-shmTOR在调节mTOR途径方面的治疗潜力,但其抗炎机制需要进一步研究.
研究的目的:
- 在缺氧视网膜病变模型中研究AAV2-shmTOR的抗炎作用.
- 阐明参与AAV2-shmTOR介导的炎症减轻的分子途径.
主要方法:
- 使用了体内氧气诱导视网膜病变模型和体内rMC1穆勒细胞模型.
- 在低氧条件下评估mTOR表达和信号通路激活.
- 量化了CCL3分泌和微质迁移,并在体内分析了CRR5阳性微质.
主要成果:
- 在Müller细胞中,AAV2-shmTOR降低了mTOR表达,并抑制了缺氧诱导的mTOR信号传递.
- 从米勒细胞中减少的CCL3分泌导致微质迁移的减少.
- 在体内,AAV2-shmTOR降低了CCL3表达,并减少了CCR5阳性微质细胞.
结论:
- 通过向mTOR通路,AAV2-shmTOR在缺氧视网膜病变中显示出抗炎作用.
- 该疗法有效调节CCL3-CCR5通路,减少缺氧驱动的炎症.
- AAV2-shmTOR为具有炎症特征的视网膜疾病提出了一种新的治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K


